Genistein Restores Nitric Oxide Bioavailability and Attenuates Oxidative Stress in Angiotensin II-Induced Hypertensive Mice
Open Access
- 16 June 2026
- journal article
- Published by The Korean Society of Food Science and Nutrition in Preventive Nutrition and Food Science
- Vol. 31 (3)
Abstract
Genistein is a dietary isoflavone that is abundant in soy products and has been suggested to exert cardiovascular protective effects; however, its role in hypertension remains incompletely defined. Here, we investigated whether genistein ameliorates angiotensin II (Ang II)-induced hypertension and endothelial dysfunction using complementary in vivo, ex vivo, and in vitro models. The oral administration of genistein substantially attenuated Ang II-induced elevations in systolic and diastolic blood pressure in mice without affecting body weight. Histological analyses revealed that genistein alleviated aortic wall thickening and smooth muscle hypertrophy, whereas vascular reactivity assays demonstrated improved endothelium-dependent relaxation while preserving the endothelium-independent responses. In isolated murine aortic rings, genistein reversed Ang II-induced hypercontractility and restored acetylcholine-mediated vasodilation. Furthermore, in human umbilical vein endothelial cells, genistein suppressed the Ang II-induced overproduction of reactive oxygen species (ROS) and restored nitric oxide (NO) bioavailability. Mechanistically, genistein improved endothelial redox-NO coupling, accompanied by transcriptional remodeling of the redox/NO axis [e.g., suppression of nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) and nitric oxide synthase 2 (NOS2) and restoration of nitric oxide synthase 3 (NOS3)], which is consistent with reduced ROS and enhanced NO bioavailability. Collectively, our findings identify genistein as a potent endothelial-protective agent that ameliorates Ang II-induced hypertension, highlighting its therapeutic potential in cardiovascular disease driven by vascular dysfunction.Keywords
Funding Information
- National Natural Science Foundation of China (82000462)
- National Natural Science Foundation of China (82170883)
This publication has 77 references indexed in Scilit:
- Peroxisome Proliferator-activated Receptor γ (PPARγ) as a Molecular Target for the Soy Phytoestrogen GenisteinJournal of Biological Chemistry, 2003
- The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal womenAtherosclerosis, 2002
- Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA..Biological and Pharmaceutical Bulletin, 2001
- Endothelial dysfunction and peroxynitrite formation are early events in angiotensin‐induced cardiovascular disordersThe FASEB Journal, 2000
- Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor βEndocrinology, 1998
- Genistein, the Dietary-Derived Angiogenesis Inhibitor, Prevents LDL Oxidation and Protects Endothelial Cells From Damage by Atherogenic LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- A Soy Protein Isolate Rich in Genistein and Daidzein and Its Effects on Plasma Isoflavone Concentrations, Platelet Aggregation, Blood Lipids and Fatty Acid Composition of Plasma Phospholipid in Normal MenThe Journal of Nutrition, 1996
- Quantification of genistein and genistin in soybeans and soybean productsFood and Chemical Toxicology, 1996
- INHIBITORY EFFECTS OF THE TYROSINE KINASE INHIBITOR GENISTEIN ON MAMMALIAN DNA TOPOISOMERASE-II1989
- Genistein, a specific inhibitor of tyrosine-specific protein kinases.Journal of Biological Chemistry, 1987